Reduced folate carrier mutations are not the mechanism underlying methotrexate resistance in childhood acute lymphoblastic leukemia.
Kaufman Y, Drori S, Cole PD, Kamen BA, Sirota J, Ifergan I, Arush MW, Elhasid R, Sahar D, Kaspers GJ, Jansen G, Matherly LH, Rechavi G, Toren A, Assaraf YG.
Kaufman Y, et al. Among authors: drori s.
Cancer. 2004 Feb 15;100(4):773-82. doi: 10.1002/cncr.20018.
Cancer. 2004.
PMID: 14770434
Free article.